Ishikawa, C., Senba, M., & Mori, N. (2018). Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines. Oncol Lett.
Chicago ZitierstilIshikawa, Chie, Masachika Senba, und Naoki Mori. "Effects of NVP-BEZ235, a Dual Phosphatidylinositol 3-kinase/mammalian Target of Rapamycin Inhibitor, On HTLV-1-infected T-cell Lines." Oncol Lett 2018.
MLA ZitierstilIshikawa, Chie, Masachika Senba, und Naoki Mori. "Effects of NVP-BEZ235, a Dual Phosphatidylinositol 3-kinase/mammalian Target of Rapamycin Inhibitor, On HTLV-1-infected T-cell Lines." Oncol Lett 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.